March 6th 2025:
The MedTrainPlus Mid-Term Review took place on 6th March 2025 at University of Galway, marking a pivotal milestone for this EU medical device research and training initiative. Coordinated by Professor Abhay Pandit, the event welcomed representatives from the European Research Executive Agency (REA), including Brigitta Judit Bosze, and Programme Manager Dr Manish Biyani. Principal investigators and postdoctoral fellows from University of Galway, the National Institute for Bioprocessing Research and Training, Trinity College Dublin, University College Dublin and the Royal College of Surgeons in Ireland gathered to showcase the program’s progress.
This all-Ireland network fosters meaningful collaboration across academia, industry, and healthcare settings, enabling fellows to undertake cutting-edge, impact-driven research. Research being carried out as part of the MedTrain+ programme spans four core themes, designed to address pressing healthcare needs. Projects presented during the review included development of regenerative therapies for myocardial recovery, investigation of novel tools to study immune-biomaterial interactions, predictive tools for chronic pain diagnostivs and teh integration of health economics and precision medicine in medical device design.
Through a structured three-year fellowship, postdoctoral researchers are trained in entrepreneurship, communication, and career development. Industry placements enhance cross-sector mobility, while involvement in public and patient engagement engagement initiatives inspire the next generation of MedTech innovators.
MedTrain+ demonstrates how targeted EU investment can catalyze high-impact, interdisciplinary research and talent development, shaping a healthier, more innovative, and more inclusive future. As a scalable model under Horizon Europe, MedTrain+ is setting a new standard for collaborative research across the continent.
This project has received €14M funding from the European Union’s Horizon Europe Excellent Science programme under Grant Agreement No 101081457 and in part from CÚRAM, Research Ireland Centre for Medical Devices [under Grant Reference 13/RC/2073_P2].
Ends.
